Schonfeld Strategic Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,400
| Closed | -$40.7K | – | 2427 |
|
|
2024
Q4 | $40.7K | Sell |
13,400
-48,900
| -78% | -$149K | ﹤0.01% | 1815 |
|
|
2024
Q3 | $323K | Sell |
62,300
-131,291
| -68% | -$681K | ﹤0.01% | 1481 |
|
|
2024
Q2 | $498K | Buy |
+193,591
| New | +$498K | ﹤0.01% | 1363 |
|
|
2024
Q1 | – | Sell |
-266,039
| Closed | -$2.34M | – | 2263 |
|
|
2023
Q4 | $2.34M | Buy |
266,039
+64,405
| +32% | +$566K | 0.02% | 690 |
|
|
2023
Q3 | $2.31M | Buy |
201,634
+117,634
| +140% | +$1.35M | 0.02% | 678 |
|
|
2023
Q2 | $2.13M | Buy |
84,000
+28,999
| +53% | +$734K | 0.02% | 730 |
|
|
2023
Q1 | $1.77M | Sell |
55,001
-116,350
| -68% | -$3.75M | 0.02% | 723 |
|
|
2022
Q4 | $3.16M | Sell |
171,351
-45,548
| -21% | -$841K | 0.03% | 648 |
|
|
2022
Q3 | $5.86M | Buy |
+216,899
| New | +$5.86M | 0.05% | 481 |
|
|
2021
Q3 | – | Sell |
-9,900
| Closed | -$293K | – | 2378 |
|
|
2021
Q2 | $293K | Buy |
+9,900
| New | +$293K | ﹤0.01% | 1447 |
|
|
2018
Q2 | – | Sell |
-83,700
| Closed | -$2.58M | – | 999 |
|
|
2018
Q1 | $2.58M | Sell |
83,700
-11,657
| -12% | -$359K | 0.19% | 153 |
|
|
2017
Q4 | $3.41M | Buy |
+95,357
| New | +$3.41M | 0.28% | 102 |
|